| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |